NCT02007057

Brief Summary

Most arthroscopic surgeries of the shoulder are currently performed as an outpatient. The postoperative analgesia should be optimal. General anesthesia allows for any arthroscopic surgery but does not provide a satisfactory postoperative analgesia . The locoregional anesthesia is recommended and includes several techniques: the interscalene nerve block, the suprascapular nerve block, intra-articular injection of local anesthetic and subacromial infiltration. The interscalene nerve block is currently the gold standard for anesthesia and postoperative analgesia for arthroscopic shoulder surgery with a success rate above 80% . However it must be carried out by teams experienced in the locoregional anesthesia because it is operator -dependent. The suprascapular nerve block is a simple technique that can be performed by the surgeon after surgery , effective in arthroscopic shoulder surgery , less invasive than the interscalene nerve block and exposing the patient to fewer complications. However, his interest was not assessed in the repair of tendons of the rotator cuff. The main hypothesis of this study is that the suprascapular nerve block is as effective as the interscalene nerve block in the prevention of early postoperative pain after arthroscopic repair of the infra and / or the supraspinatus rotator cuff tendons, without increasing the analgesic consumption while reducing the risk of complications related to regional anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Nov 2013

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

November 29, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 10, 2013

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
Last Updated

February 9, 2015

Status Verified

February 1, 2015

Enrollment Period

1 year

First QC Date

November 29, 2013

Last Update Submit

February 6, 2015

Conditions

Keywords

Suprascapular nerve blockInterscalene nerve block

Outcome Measures

Primary Outcomes (1)

  • Self-assessment of the mean shoulder pain

    Visual analog scale (VAS) during 2 days postoperatively

Secondary Outcomes (2)

  • Self assessment of shoulder pain

    VAS twice daily during the first postoperative week

  • Complications of locoregional anesthesia

    Yes or No during the first 24 hours

Study Arms (2)

Interscalene nerve block

ACTIVE COMPARATOR

Interscalene block is performed preoperatively with ultrasound guidance and neurostimulation 0.8 milliampere. The block is performed using "in-plane" approach with a needle of 50 mm for a neurostimulation. During the injection, it is verified that the diffusion extends to the anterior and posterior space. If the posterior distribution is limited, the needle is remobilized to obtain an overall diffusion: a bolus of 20 mL of ropivacaine 0.75% is made by the anesthetist. The effectiveness of the nerve block is checked before the start of surgery.

Procedure: Interscalene nerve block

Suprascapular nerve block

EXPERIMENTAL

The suprascapular block is performed at the end of surgery when the incisions are closed but before the removal of the surgical drapes. The material used is a compound of a 10 cc syringe sterile equipment, a green intramuscular needle (14 gauge) and a bulb 10 cc of 0.75% Ropivacaine. The injection of 10 cc is realized by the technical princeps

Procedure: Suprascapular nerve block

Interventions

Suprascapular nerve block
Interscalene nerve block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged over 18 years
  • Arthroscopic repair of infra and / or supraspinatus tendon of the rotator cuff with or without associated procedure on the biceps, the acromion-clavicular joint or acromion
  • Informed consent

You may not qualify if:

  • Allergy to local anesthetics (ropivacaine, bupivacaine, xylocaine)
  • Previous surgery on the involved shoulder
  • Severe or morbid obesity (BMI\> 35)
  • Psychiatric disorders (impossible self-assessment of the pain)
  • Patient unfit physically, mentally or legally to give informed consent
  • Patient refusal
  • Pregnant or lactating women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Ambroise Pare

Boulogne-Billancourt, 92100, France

Location

MeSH Terms

Conditions

Rotator Cuff InjuriesPain

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Philippe Hardy, MD, PhD

    Ambroise Pare Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician Responsible of Clinical Research

Study Record Dates

First Submitted

November 29, 2013

First Posted

December 10, 2013

Study Start

November 1, 2013

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

February 9, 2015

Record last verified: 2015-02

Locations